COLETTE DAVIS: Open Payments
NPI 1902386378 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 25 payments from 9 companies in 2025. Trend: 2023 $177 · 2024 $52 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $215 |
| Janssen Biotech, Inc. | 1 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Madrigal Pharmaceuticals | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| PFIZER INC. | 2 | $34 |
| GENZYME CORPORATION | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Braintree Laboratories, Inc. | 1 | $23 |
Products named: RINVOQ, TREMFYA, DUPIXENT, ENTYVIO, REZDIFFRA, MAVYRET, ZENPEP, SUFLAVE.
Industry payments across OR — which companies pay providers there.
